Oscar Health (OSCR) Depreciation & Amortization (CF) (2020 - 2026)

Oscar Health's Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $7.0 million for Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 4.28% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.2 million (down 5.9% YoY) and the FY2025 annual result came in at $28.9 million, down 9.97% from the prior year.
• Depreciation & Amortization (CF) was $7.0 million for Q1 2026 at Oscar Health, down from $7.9 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $9.2 million in Q3 2023 and bottomed at $3.7 million in Q2 2022.
• A 5-year average of $6.7 million and a median of $7.3 million in 2025 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) surged 139.01% — and 2024, when it decreased 18.4%.
• Oscar Health's Depreciation & Amortization (CF) stood at $3.7 million in 2022, then surged by 107.28% to $7.7 million in 2023, then grew by 18.68% to $9.2 million in 2024, then fell by 14.15% to $7.9 million in 2025, then retreated by 11.03% to $7.0 million in 2026.
• Business Quant data shows OSCR's Depreciation & Amortization (CF) at $7.0 million in Q1 2026, $7.9 million in Q4 2025, and $7.3 million in Q3 2025.